Medically Assisted Reproduction in the UAE: Consent, Embryo Controls, Storage, and Clinic Liability

Medically assisted reproduction combines highly personal medical decisions with one of the most tightly regulated areas of healthcare. An IVF cycle may involve clinical eligibility, written consent, collection and storage of sperm or ova, fertilisation, embryo transfer, genetic testing, long-term cryopreservation, cross-border movement of reproductive material and decisions about what happens to stored material after death, separation or expiry of the storage period.

In the UAE, these issues are governed principally by Federal Law No. 7 of 2019 Concerning Medically Assisted Reproduction, as materially amended by Federal Decree-Law No. 17 of 2023. The statutory framework is supplemented by Cabinet Resolution No. 64 of 2020 as the Executive Regulation, as amended by Cabinet Resolution No. 124 of 2024, together with health-authority standards and licensing requirements.

The 2023 amendment was significant. It expanded the federal law to all centres in the UAE, including free zones, allowed individual emirates to regulate assisted reproduction through local legislation in specified areas, broadened access for certain non-Muslim persons without a marriage certificate, and amended key provisions concerning permitted techniques, embryo handling, destruction, research and enforcement.

For clinics and patients, the practical lesson is that assisted reproduction is not governed by one consent form signed at the start of treatment. Different stages require different legal permissions, storage decisions, laboratory controls and continuing documentation.

The federal law applies across the UAE, including free zones

Article 2, as amended in 2023, applies the federal law to assisted-reproduction centres throughout the UAE, including centres established in free zones.

The same amendment recognises that an emirate may regulate medically assisted reproduction under its own local legislation, subject to the federal allocation of mandatory matters. Where local legislation does not specifically address an issue, the federal law remains relevant.

This means a clinic cannot rely on the federal statute alone. It must also identify the rules of the competent health authority in the emirate where it operates.

Dubai, for example, introduced a new Standards for Assisted Reproductive Medicine Center framework effective from 28 February 2026, replacing the previous Dubai fertility-centre standards. Local clinical, staffing, laboratory and licensing requirements should therefore be checked against the current health-authority standard rather than an older IVF manual.

Only licensed centres may provide regulated assisted-reproduction techniques

Articles 5 to 7 establish the licensing structure. A centre may not be established, operated or managed without the required health-authority licence, and assisted-reproduction techniques may be performed only in centres licensed for that purpose.

The 2023 amendment also permits local health authorities to add new techniques, provided the statutory controls are respected.

For a clinic considering a new laboratory method, genetic technique or reproductive procedure, the first compliance question is therefore not whether the method is available internationally. It is whether the technique falls within the UAE and emirate-level scope of authorised practice.

Eligibility and consent for married couples

Article 8 contains the core conditions for using medically assisted reproduction.

For spouses, the centre must ordinarily verify an official document proving the continuation of the marital relationship. Both spouses must give written consent to use the assisted-reproduction technique, and the consent is to be issued at the centre in their presence.

The procedure must also be medically appropriate, supported by the required specialist assessment concerning risk to the woman and foetus, and performed by a properly licensed physician.

Before treatment, the centre must give the spouses a detailed explanation of:

• the selected reproductive technique;
• the stages of the procedure;
• potential adverse effects and complications;
• the financial cost; and
• the realistic pregnancy rate for comparable cases at that centre.

This makes consent both a legal and informational process. A signature without adequate counselling is not the same as a properly documented informed decision.

Non-Muslim persons without a marriage certificate

Federal Decree-Law No. 17 of 2023 introduced an important exception to the ordinary marriage-document requirement.

Under Article 8(2), non-Muslim concerned persons who do not have a marriage certificate may apply to the relevant health authority for permission to use medically assisted reproduction techniques.

The amended provision requires a declaration concerning attribution of the child's lineage to either of them. That declaration must be certified by the competent authority in the relevant country of nationality from which the child will acquire citizenship, in accordance with the form and procedures prescribed by the UAE authorities.

This is not an automatic clinic-level exception. The parties must use the health-authority permission route and satisfy the required lineage and documentation controls.

Consent should be treated as procedure-specific

Clinics should avoid treating one broad IVF consent as covering every later clinical or laboratory decision.

Separate consent questions can arise for:

• ovarian stimulation and egg retrieval;
• sperm collection;
• fertilisation;
• embryo transfer;
• cryopreservation;
• renewal of the storage period;
• preimplantation genetic diagnosis or testing;
• research involving reproductive material;
• movement of specimens into or outside the UAE; and
• destruction or disposal decisions.

The 2024 amendment to the Executive Regulation reinforces this approach by requiring specific consent mechanisms for preservation of unfertilised ova, seminal fluid and fertilised ova and by requiring notification to the health authority through mechanisms protecting confidentiality.

Third-party sperm and egg fertilisation remains prohibited

Article 9 continues to prohibit core third-party gamete combinations.

A centre may not fertilise sperm taken from a husband with an ovum taken from a woman other than his wife, and may not fertilise an ovum taken from a wife using sperm from a man other than her husband.

The amended provision also allows the Cabinet to determine other prohibited cases.

The safest compliance approach is therefore not to infer donor-gamete permission from broader 2023 reforms. Any proposed use of third-party reproductive material must be tested directly against the current federal text, applicable local rules and health-authority approvals.

Surrogacy requires particularly careful current-law review

The 2023 amendment removed the earlier express federal wording that prohibited certain implantation into another woman's uterus. However, the amendment did not create a complete federal contractual, parentage and clinical code governing every surrogacy arrangement across the UAE.

Because Article 2 now permits emirate-specific regulation in parts of the assisted-reproduction field, surrogacy should be analysed separately by emirate and by the applicable health-authority framework. Removal of an old prohibition should not be treated as equivalent to unrestricted federal permission for every arrangement.

This article therefore focuses on the clearly regulated federal rules concerning consent, embryos, gametes, storage and clinic duties.

How many ova may be fertilised?

Article 10 allows multiple ova to be fertilised where they are sufficient for implantation more than once, subject to the Executive Regulation.

The law therefore permits creation of more fertilised ova than are transferred in one cycle, but the centre must operate within regulatory limits concerning fertilisation, implantation and preservation.

The purpose of the regulatory framework is to permit clinically useful embryo preservation while preventing uncontrolled creation, mixing, substitution or misuse of reproductive material.

Fertilised ova may generally be preserved for five years

Article 10 permits fertilised ova to be preserved for future implantation for a period of five years.

The period may be renewed for similar periods on the basis of a written request from both spouses under the statutory framework.

Storage therefore requires active legal administration. A clinic should not simply place embryos into indefinite cryopreservation without a renewal mechanism.

Its storage system should identify:

• the start date of preservation;
• the statutory expiry date;
• the persons whose consent controls renewal;
• the date and form of renewal request;
• current marital or legal status where relevant;
• contact information;
• the number and identity of stored samples; and
• the legal action required if no renewal is received.

Unfertilised ova and sperm have their own five-year storage framework

Article 11 allows frozen unfertilised ova or sperm to be preserved for five years on written request from the relevant concerned person, with renewal for similar periods.

This distinction matters because a fertilised ovum involves different consent and destruction rules from an unfertilised egg or an individual sperm sample.

The 2024 Executive Regulation amendment expressly requires separate consent mechanisms for preserving unfertilised ova and seminal fluid and requires the centre to maintain an approved preservation process.

The 2024 amendment strengthened laboratory traceability

Cabinet Resolution No. 124 of 2024 replaced key parts of the Executive Regulation concerning preservation.

Centres must maintain mechanisms that identify the steps in preservation, verify the place and time of preservation, address what happens if a person's sample cannot be located, record the effectiveness and success rates of preservation processes and provide for lawful disposal.

The amended Regulation also requires:

• separation of samples from persons with contagious disease from other preserved samples;
• specific consent for freezing unfertilised ova;
• specific consent for freezing seminal fluid;
• specific consent for preservation of fertilised ova;
• notification to the health authority through the prescribed mechanism; and
• protection of confidentiality of the sample owners' data.

For a fertility clinic, chain of custody is therefore a legal-risk issue as well as a laboratory-quality issue.

Mixing or substitution of reproductive material is a critical compliance risk

Article 10 requires centres to take the highest attainable medical and other measures to prevent ova from being mixed or used contrary to the law.

Article 18 reinforces the obligation by requiring the highest degree of care and precaution in handling frozen fertilised and unfertilised ova and sperm so that they are not unlawfully used, exploited, substituted or mixed.

A modern ART laboratory should therefore maintain controls such as:

• unique patient and sample identifiers;
• double witnessing or equivalent validated electronic witnessing;
• documented chain of custody;
• controlled access to cryostorage;
• temperature and equipment monitoring;
• incident-reporting procedures;
• sample-location reconciliation;
• backup systems; and
• clear disaster-recovery arrangements.

The exact operational standard depends on the applicable health authority, but the underlying federal duty to prevent mixing and misuse is explicit.

When must fertilised ova be destroyed?

Article 13 provides specific destruction events for fertilised ova that have not been implanted.

Under the current federal framework, destruction is required where:

• either spouse dies;
• the marital relationship ends;
• both spouses request destruction; or
• the preservation period expires without a request for extension.

The Executive Regulation, as amended in 2024, requires clinics to maintain an approved mechanism for disposal of stored fertilised and unfertilised ova or sperm in circumstances including death and divorce or separation.

These events should be built into the clinic's storage-management system rather than dealt with only after a dispute arises.

Unfertilised ova and sperm are destroyed under different triggers

Article 13 separately provides that unfertilised ova and frozen sperm are to be destroyed where the relevant concerned person dies, requests destruction, or allows the preservation period to expire without renewal.

For individually stored gametes, the clinic should therefore identify whose instructions control the sample and should not assume that the rules governing jointly created fertilised ova apply in the same way.

Legal change in relationship status can create immediate storage consequences

One of the highest-risk situations for clinics is a change in legal status while embryos remain frozen.

If a married couple divorces, separates in a legally relevant way, or one spouse dies, the clinic should not continue to treat the stored embryos as though the original reproductive plan remains unchanged.

The facility should immediately review:

• the statutory destruction rule;
• the current Executive Regulation;
• the patient's consents;
• the health-authority forms;
• any pending court or family-law issue; and
• whether the material may lawfully remain in storage during any necessary verification process.

Because the 2023 amendment also introduced access for certain non-Muslim persons without a marriage certificate, clinics should obtain current health-authority guidance where older spouse-based statutory terminology does not map neatly onto a newer permitted treatment category.

Research involving reproductive material is restricted

Article 14 prohibits commercial use of unfertilised or fertilised ova and frozen sperm, prohibits non-therapeutic genetic modification, and prohibits disposing of reproductive material to others.

Research and experiments are not unrestricted. The amended Article 14 allows research or experiments only after the written consent required from the spouses or concerned persons, as applicable, and subject to the conditions and controls established by the Executive Regulation or health authority.

A clinic should therefore separate ordinary clinical consent from research consent and should not repurpose stored material for training, validation, research or commercial activity merely because it is no longer required for treatment.

Preimplantation genetic diagnosis is permitted within statutory controls

Article 15 permits preimplantation genetic diagnosis for identifying hereditary diseases, subject to the required written consent and measures designed to avoid harm to the fertilised ovum.

PGD or related genetic testing should therefore be supported by:

• appropriate genetic counselling;
• clear explanation of what is being tested;
• the required written consent;
• validated laboratory procedures;
• documentation of the clinical indication;
• confidential handling of genomic and reproductive information; and
• compliance with any additional health-authority or human-genome regulation.

Genetic testing for disease detection should not be confused with prohibited non-therapeutic genetic modification.

Cross-border movement of embryos and gametes is controlled

Article 17 prohibits sending unfertilised or fertilised ova or sperm out of the UAE, or bringing such specimens into the UAE, except in accordance with the controls and procedures established by the Executive Regulation.

The 2024 amendment expressly provides that transfer of fertilised ova into or out of the UAE is limited to married couples or other persons falling within the permitted concerned-person framework.

Cross-border transfer should therefore be treated as a regulatory process, not as an ordinary courier shipment.

The clinic should verify:

• health-authority approval;
• identity and ownership of the specimen;
• consent to transfer;
• destination-centre licensing;
• cryogenic transport controls;
• chain of custody;
• customs or import/export requirements;
• insurance; and
• the receiving country's legal requirements.

Confidentiality is an express statutory duty

Article 16 requires centre personnel to maintain the confidentiality of data and information relating to people using medically assisted reproduction services in accordance with UAE law.

Reproductive records can contain unusually sensitive information: infertility diagnoses, genetic results, marital or relationship status, gamete ownership, lineage declarations, embryo numbers and future reproductive intentions.

Clinics should combine the ART-specific confidentiality duty with the wider UAE healthcare-data framework, including secure access, retention and electronic health-information controls.

Recordkeeping is central to defending a clinic

Article 21 requires centres to keep the necessary registers recording assisted-reproduction procedures and to maintain internal control mechanisms approved by the competent health authority.

A clinic facing a later complaint should be able to reconstruct the complete treatment pathway from the medical record.

Important records include:

• identity verification;
• marriage or permitted alternative documentation;
• health-authority approval where required;
• informed-consent forms;
• clinical counselling;
• egg and sperm collection records;
• laboratory witnessing;
• fertilisation records;
• embryo grading and transfer;
• genetic-testing consent and results;
• cryostorage location;
• storage-renewal requests;
• health-authority notifications;
• specimen-transfer records;
• destruction authorisations; and
• adverse incidents and corrective action.

Clinic liability has several different layers

A fertility-centre dispute should not be reduced to one generic concept of “medical malpractice”. A clinic can face several forms of exposure at the same time.

Regulatory and licensing liability

The competent health authority supervises ART centres, investigates complaints and violations, and can impose disciplinary action.

Article 24 authorises sanctions against centres including reprimands, notices, fines, temporary suspension and cancellation of the licence. Licensed health staff can also face professional sanctions.

A serious compliance failure can therefore threaten the clinic's ability to continue operating even where a patient has not yet obtained civil compensation.

Criminal exposure under the assisted-reproduction statute

The Law contains specific penal provisions for serious violations.

For example, violations involving unlicensed activity, prohibited reproductive practices, unlawful use of reproductive material and certain cross-border specimen conduct can attract imprisonment and substantial fines. Separate offences cover unlawful handling, destruction and misuse of stored ova or sperm and breaches of treatment-eligibility controls.

The exact offence and penalty should be matched to the current amended article before any criminal-risk advice is given.

Civil and medical-liability exposure

Clinical negligence can also engage Federal Decree-Law No. 4 of 2016 Concerning Medical Liability, as amended.

That framework defines medical error by reference to matters such as failure to meet the technical knowledge and professional standard expected of a practitioner of the same degree and specialty.

A fertility claim may therefore involve both a breach of the specialist ART statute and an allegation that the physician, embryologist or facility failed to meet professional standards.

A statutory breach does not automatically determine civil compensation

A clinic can violate a regulatory rule without every patient automatically becoming entitled to the same measure of damages.

A civil claimant will ordinarily need to establish the legally relevant elements of liability, which may include the breach, actual damage and causation.

Examples of potentially compensable ART disputes can include:

• use of the wrong reproductive sample;
• loss or destruction of embryos through negligent handling;
• implantation outside lawful consent;
• failure to follow required storage instructions;
• failure to diagnose or disclose a material treatment risk;
• laboratory error affecting embryo viability;
• unauthorised disclosure of reproductive or genetic data; or
• failure to comply with a lawful destruction or transfer instruction.

The legal measure of loss will depend heavily on the facts, causation and the remedy recognised by the applicable court or medical-liability process.

Wrong-sample incidents create exceptional risk

Few ART incidents create greater legal exposure than embryo, sperm or ovum misidentification.

Such an event may engage:

• the Article 10 duty to prevent mixing;
• the Article 18 duty of the highest care and precaution;
• patient-consent violations;
• medical-liability claims;
• lineage and personal-status consequences;
• professional disciplinary proceedings;
• criminal provisions; and
• mandatory regulator notification or investigation.

For this reason, specimen-identification systems should be designed around prevention and rapid auditability rather than relying solely on individual staff memory.

Failure of cryostorage equipment can create both clinical and contractual disputes

Cryopreservation depends on laboratory equipment, monitoring, liquid-nitrogen management, alarms, backup arrangements and emergency response.

If embryos or gametes are lost through a storage failure, liability analysis may involve:

• whether the clinic followed mandatory preservation standards;
• whether equipment was maintained and validated;
• whether alarms were monitored;
• whether backup storage existed;
• whether the sample was lawfully within its storage period;
• whether consent for storage remained effective;
• what reproductive opportunity was actually lost; and
• whether a manufacturer or maintenance contractor also contributed to the event.

The patient agreement cannot be assumed to exclude mandatory clinical or regulatory duties.

Closure of a centre does not end responsibility for stored reproductive material

Article 31 specifically addresses closure, suspension or termination of a centre's licence.

Where a centre closes, the competent health authority must take necessary measures to protect frozen fertilised and unfertilised ova and sperm and protect the rights of patients receiving or continuing treatment, including continuity of necessary medical services.

A clinic should therefore maintain a contingency plan for transfer of cryopreserved material in the event of insolvency, licence suspension, disaster or permanent closure.

Dubai's 2026 standard increases the importance of local compliance

Dubai Health Authority issued a new Standards for Assisted Reproductive Medicine Center framework in 2026, replacing its previous fertility-centre standards.

The current standard addresses licensing requirements, terms and conditions for assisted-reproduction procedures, approved ART procedures, genetic testing and other operational requirements.

A Dubai clinic should therefore audit federal compliance and DHA compliance separately. Satisfying the federal statute does not remove local licensing, staffing, quality and technical obligations.

A practical patient-consent matrix

Stage	Key legal / compliance question
Treatment eligibility	Are the parties within the permitted federal and health-authority treatment pathway?
IVF / ART procedure	Has written informed consent been obtained after the required explanation of technique, risks, cost and realistic success rate?
Fertilisation	Are the sperm and ovum sources lawful and correctly identified?
Embryo storage	Is there valid consent, an accurate five-year storage clock and a renewal process?
Egg / sperm freezing	Has the concerned person signed the required preservation consent?
PGD / genetic testing	Is the testing lawfully indicated and supported by the required written consent?
Research	Is there separate written consent and approval under the applicable research controls?
Cross-border transfer	Have the Executive Regulation and health-authority transfer procedures been satisfied?
Destruction	Has a statutory destruction event occurred, and is the clinic using the required documented process?

A practical compliance checklist for ART centres

1. Verify licensing. Ensure the facility and every relevant professional hold the current authorisations for the services actually provided.
2. Identify the patient's legal pathway. Married couple, permitted non-Muslim applicants without a marriage certificate, or another category recognised by the competent authority.
3. Use stage-specific consent. Separate treatment, storage, genetic testing, research, transfer and destruction decisions.
4. Maintain laboratory traceability. Every sample should be identifiable through collection, processing, storage, thawing, transfer and destruction.
5. Track five-year periods. Do not rely on manual reminders for renewal.
6. Monitor legal-status changes. Death, divorce, separation and expiry can change what the clinic is legally permitted to do.
7. Protect against mixing. Use validated witnessing and sample-location controls.
8. Control cross-border movement. Obtain required approvals before accepting or releasing reproductive material internationally.
9. Protect confidentiality. Restrict access to fertility, genetic and lineage information.
10. Maintain closure contingency plans. Know where stored material can be lawfully transferred if the facility cannot continue operating.
11. Audit local rules separately. Federal compliance does not replace DHA, DoH, MOHAP or other applicable health-authority standards.
12. Escalate incidents immediately. A sample mix-up, cryostorage failure or consent discrepancy should trigger clinical, regulatory and legal review before further use of affected material.

Key takeaway

The UAE assisted-reproduction regime is built around controlled access, informed consent and strict protection of reproductive material. Federal Law No. 7 of 2019, as amended in 2023, allows medically assisted reproduction only within licensed centres and imposes specific rules on who may receive treatment, the sperm and ova that may be used, how fertilised and unfertilised material is stored, when it must be destroyed, how genetic testing and research are controlled and how specimens may move across borders.

Storage is particularly important. Fertilised ova can generally be preserved for five years and renewed for similar periods under the statutory consent framework; unfertilised ova and sperm have their own five-year renewable regime. Death, termination of the marital relationship, a valid destruction request or expiry without renewal can trigger mandatory destruction.

The 2024 Executive Regulation amendment strengthens preservation and chain-of-custody requirements through specific consent, sample-location, disposal, segregation and health-authority notification controls. For clinics, these rules mean that embryo and gamete management is not simply a laboratory function—it is a regulated legal custody process.

Where something goes wrong, liability may arise at several levels: health-authority discipline, statutory criminal offences, professional responsibility and civil medical liability. The strongest defence for a fertility centre is therefore an auditable treatment record showing lawful eligibility, informed consent, correct specimen identification, continuous storage control and compliance with the current federal and emirate-level standards.

HZ Legal can assist fertility centres, healthcare groups, physicians and patients with UAE assisted-reproduction regulation, consent and clinic documentation, embryo and gamete storage, cross-border specimen transfers, fertility-centre licensing, incident response, medical-liability disputes and health-authority investigations.

Official and authoritative sources

• UAE Legislation — Federal Law No. 7 of 2019 Concerning Medically Assisted Reproduction.
• Ministry of Health and Prevention — Federal Decree-Law No. 17 of 2023 amending Federal Law No. 7 of 2019.
• UAE Legislation — Cabinet Resolution No. 64 of 2020, Executive Regulation of the Medically Assisted Reproduction Law.
• Ministry of Health and Prevention — Cabinet Resolution No. 124 of 2024 amending the Executive Regulation.
• Dubai Health Authority — 2026 Standards for Assisted Reproductive Medicine Center circular.
• UAE Legislation — Federal Decree-Law No. 4 of 2016 Concerning Medical Liability.
• Ministry of Health and Prevention — Federal Decree-Law No. 18 of 2023 amending the Medical Liability Law.

This article provides general legal and regulatory information only and does not constitute medical advice or case-specific legal advice. Assisted-reproduction requirements depend on the patient's legal status, the technique proposed, the emirate, the competent health authority, current consent forms and local clinic standards. Exact statutory wording and current regulator approval should be checked before treatment, storage, transfer, research or destruction of reproductive material.